We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$134M
Cap. Flow
+$101M
Cap. Flow %
9.82%
Top 10 Hldgs %
32.7%
Holding
2,551
New
200
Increased
686
Reduced
655
Closed
183
Avg Time Held Equity + Options
1.8 years
Top 10 Avg Time Held Equity + Options
1.4 years
Top 20 Avg Time Held Equity + Options
1.4 years
Avg Time Held Equity only
1.8 years
Top 10 Avg Time Held Equity only
1.4 years
Top 20 Avg Time Held Equity only
1.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.06%
2 Technology 12.78%
3 Financials 6.64%
4 Communication Services 4.79%
5 Healthcare 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LBAI icon
2451
DELISTED
Lakeland Bancorp Inc
LBAI
– –
-346
Closed -$5K –
TAST icon
2452
DELISTED
Carrols Restaurant Group, Inc.
TAST
– –
-301
Closed -$3K –
SIEN
2453
DELISTED
Sientra, Inc.
SIEN
– –
-17
Closed -$1K –
FTCH
2454
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
– –
-4
Closed – –
VRTV
2455
DELISTED
VERITIV CORPORATION
VRTV
$0 ﹤0.01%
4
-4
-50% -$92
2017 Q2
8 quarters
ZYNE
2456
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-23
Closed – –
KDNY
2457
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$0 ﹤0.01%
+5
New +$76
2019 Q2
0 quarters
MGI
2458
DELISTED
MoneyGram International, Inc. New
MGI
$0 ﹤0.01%
12
-1,939
-99% -$4.34K
2016 Q4
10 quarters
IRL
2459
DELISTED
NEW IRELAND FUND INC
IRL
– –
-389
Closed -$4K –
SRNE
2460
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-2,000
Closed -$10K –
AVYA
2461
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$0 ﹤0.01%
35
-194
-85% -$2.97K
2018 Q3
3 quarters
VIVO icon
2462
DELISTED
Meridian Bioscience Inc
VIVO
– –
-153
Closed -$3K –
HIL
2463
DELISTED
Hill International, Inc. Common Stock
HIL
– –
-11,834
Closed -$35K –
ABMD
2464
DELISTED
Abiomed Inc
ABMD
– –
-35
Closed -$10K –
SECO
2465
DELISTED
Secoo Holding Limited ADR
SECO
– –
-26
Closed -$2K –
EXTN
2466
DELISTED
Exterran Corporation
EXTN
– –
-1,635
Closed -$28K –
GCP
2467
DELISTED
GCP Applied Technologies Inc.
GCP
$0 ﹤0.01%
12
– –
2016 Q4
10 quarters
NBEV
2468
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
– –
-150
Closed -$1K –
LFC
2469
DELISTED
China Life Insurance Company Ltd.
LFC
– –
-2,916
Closed -$39K –
POLY
2470
DELISTED
Plantronics, Inc.
POLY
– –
-366
Closed -$17K –
ENDP
2471
DELISTED
Endo International plc
ENDP
– –
-24
Closed – –
EMWP
2472
DELISTED
Eros Media World PLC
EMWP
$0 ﹤0.01%
11
– –
2016 Q4
10 quarters
ATRS
2473
DELISTED
Antares Pharma, Inc.
ATRS
– –
-1
Closed – –
EPAY
2474
DELISTED
Bottomline Technologies Inc
EPAY
– –
-464
Closed -$23K –
PVG
2475
DELISTED
PRETIUM RESOURCES INC.
PVG
– –
-1
Closed – –

Similar funds

Parallel Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Parallel Advisors held 2,551 positions worth $1.03B, up 15% from $891M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Parallel Advisors deployed $101M of net new capital in Q2 2019, opening 200 new positions and adding to 686 existing holdings. Its largest new stake was Onto Innovation: 157,557 shares worth $5.47M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 56% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $34.9M trimmed.

  • Parallel Advisors's largest Q2 2019 buy was Onto Innovation: 157,557 shares worth $5.47M.
  • Parallel Advisors added most to iShares Core S&P Total US Stock Market ETF in Q2 2019, an estimated $59.5M increase.
  • Parallel Advisors's biggest Q2 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $34.9M.
  • Parallel Advisors fully exited Vanguard Short-Term Treasury ETF in Q2 2019, selling an estimated $553K.
  • Parallel Advisors's ten largest holdings make up 33% of its $1.03B portfolio in Q2 2019.
  • Parallel Advisors opened 200 new positions and closed 183 in Q2 2019.
  • Parallel Advisors's portfolio value rose 15% quarter-over-quarter to $1.03B.

Based on Parallel Advisors's 13F filing for Q2 2019, filed 5 Aug 2019.